Kenneth C. Fang, M.D.

Chief Medical Officer

VP, Translational Research & Clinical Development

Kenneth C. Fang, M.D., is a distinguished physician-scientist and life sciences entrepreneur with extensive industry experience in biomarker discovery and molecular diagnostics. He leads development of Integrated Diagnostics’ programs for early detection of complex diseases, including lung cancer and Alzheimer’s disease. Prior to joining the company in late 2010, Dr. Fang was Senior Director for Clinical Development at XDx, a molecular diagnostics firm.

Earlier in his career, for nearly two decades, Dr. Fang was an Assistant Professor of Medicine at the University of California at San Francisco (UCSF), where he garnered RO1 funding from the National Institutes of Health and was a Cardiovascular Research Institute (CVRI) investigator.

Before joining Integrated Diagnostics, he was a co-founder of Modus BioMedicine, where he led research and development of therapeutics and companion diagnostics to combat rejection of transplanted organs and other immune-mediated diseases.

Dr. Fang received his B.A. in biochemistry and his M.D. from the University of Pennsylvania. He completed an internal medicine residency and a fellowship in pulmonary and critical care medicine at UCSF. He later completed postdoctoral research training at CVRI and is board certified in internal medicine, critical care medicine and pulmonology.